Use of Biocompatible Sorafenib-gold Nanoconjugates for Reversal of Drug Resistance in Human Hepatoblatoma Cells

The present study identifies the potential of highly biocompatible SF-GNP nano-conjugate to enhance the chemotherapeutic response to combat drug resistance in cancer cells. We developed a stable colloidal suspension of sorafenib-gold nanoconjugate (SF-GNP) of <10 nm size in aqueous medium for rev...

Descripción completa

Detalles Bibliográficos
Autores principales: Vishwakarma, Sandeep Kumar, Sharmila, Priyanka, Bardia, Avinash, Chandrakala, Lakkireddy, Raju, N., Sravani, G., Sastry, B. V. S., Habeeb, Md Aejaz, Khan, Aleem Ahmed, Dhayal, Marshal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561190/
https://www.ncbi.nlm.nih.gov/pubmed/28819176
http://dx.doi.org/10.1038/s41598-017-08878-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561190/
https://www.ncbi.nlm.nih.gov/pubmed/28819176
http://dx.doi.org/10.1038/s41598-017-08878-y

Ejemplares similares